Corporate Information And Statement Of Ifrs Compliance [Abstract]

BioInvent International - Filing #689618

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	As at 2021-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	BioInvent International	—	—
Domicile of entity	Sverige	—	—
Legal form of entity	AB	—	—
Address of entity's registered office	223 70 Lund	—	—
Description of nature of entity's operations and principal activities	BioInvent är ett bolag som identifierar och utvecklar antikroppar för cancerbehandling.	—	—
Statement of IFRS compliance [text block]	UTTALANDE OM ÖVERENSSTÄMMELSE MED TILLÄMPADE REGELVERK	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current inventories	—	11 506 SEK	16 848 SEK
Current trade receivables	—	15 780 SEK	370,000 SEK
Current trade payables	—	41 346 SEK	19 720 SEK
Disclosure of objectives, policies and processes for managing capital [text block]	Kapitalhantering	—	—